The Procter & Gamble Company (NYSE:PG – Get Free Report) CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the transaction, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Procter & Gamble Trading Up 0.3 %
PG opened at $179.71 on Tuesday. The firm has a 50 day simple moving average of $170.48 and a 200 day simple moving average of $169.11. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $180.43. The company has a market cap of $423.22 billion, a price-to-earnings ratio of 30.98, a price-to-earnings-growth ratio of 3.86 and a beta of 0.42. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm’s revenue was down .6% on a year-over-year basis. During the same period last year, the company earned $1.83 EPS. On average, sell-side analysts anticipate that The Procter & Gamble Company will post 6.97 earnings per share for the current year.
Procter & Gamble Announces Dividend
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of PG. Acorn Creek Capital LLC raised its holdings in Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after buying an additional 59 shares during the last quarter. Patrick M Sweeney & Associates Inc. raised its stake in shares of Procter & Gamble by 1.1% during the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after acquiring an additional 59 shares during the last quarter. Hudson Value Partners LLC boosted its holdings in shares of Procter & Gamble by 4.1% during the second quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock worth $250,000 after purchasing an additional 60 shares during the period. Traveka Wealth LLC grew its stake in shares of Procter & Gamble by 1.7% in the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock worth $616,000 after purchasing an additional 60 shares during the last quarter. Finally, Fiduciary Alliance LLC raised its position in Procter & Gamble by 2.8% during the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock valued at $371,000 after purchasing an additional 61 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on PG. Piper Sandler initiated coverage on Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price for the company. JPMorgan Chase & Co. increased their price objective on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. DZ Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research note on Thursday, August 29th. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Finally, Morgan Stanley upped their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Eight investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $180.45.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Stories
- Five stocks we like better than Procter & Gamble
- What Are Dividend Achievers? An Introduction
- How to Master Trading Discipline: Overcome Emotional Challenges
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.